Michael Fitzgerald
Seattle Children's Hospital
ORCID: 0009-0007-7533-942XAlso affiliated with Seattle University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib”.
Shuai Li, Ting Chen, Michael Fitzgerald, Shengwu Liu, Chengwei Peng +24 more
Beda Břicháček, N. M. Prashant, Tatiana Pushkarsky, Nigora Mukhamedova, Andrew J. Fleetwood +8 more
Peijun Ma, Marek Orzechowski, Allison Lemmer, Kara Rzasa, Josephine Bagnall +25 more